Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,761.07
(
0.66%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 3899

Monday, 10/04/2004 10:50:32 AM

Monday, October 04, 2004 10:50:32 AM

Post# of 257302
>> Seeing the barrage of PR, makes me wonder. <<

Let’s analyze that. The timing of today’s PR was dictated by the FDA. The timing of the PR for the start of the “208” combo trial was presumably fixed by the actual opening of that trial for enrollment. That leaves the two PR’s about the SBIR grants; these GENR could conceivably have sat on for a while to exploit the timing; e.g. GENR may have issued the Trodusquemine PR in concert with MRK’s obesity deal with NSTK.

Overall, the evidence for a financing based on this sequence of PR’s is pretty weak, IMHO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today